| Company | Acquired By | Date | Date | Value | Terms/Details |
| Acquired** | Or Merged With | Announced | Completed | (M) | |
| (Country) | (Country) | ||||
| I. BIOTECH | |||||
| Blue Ridge | Idexx Laboratories | 9/98 | 10/98 | $50 | Idexx acquired 100% of Blue Ridge's |
| Pharmaceuticals | Inc. | outstanding stock for $50M in cash, | |||
| Inc.* | notes and Idexx common shares; it also | ||||
| granted 5-year warrants to buy 0.81M | |||||
| Idexx shares at $31.59/share ($25.6M) | |||||
| and agreed to issue 1.25M Idexx shares | |||||
| over 5 years contingent on performance | |||||
| milestones | |||||
| DeKalb Genetics | Monsanto Co. | 2/98 | 11/98E | $3,700 | Monsanto already held 10% of |
| Corp. | (NYSE:MTC) | DeKalb's Class A voting shares and | |||
| 45% of its Class B non-voting shares | |||||
| in 2/98, when it said it was consider- | |||||
| ing an offer to acquire the rest; the | |||||
| definitive merger agreement was | |||||
| reached in 5/98; Monsanto will pay | |||||
| $100/share for the remaining stock; | |||||
| the Roberts family, which owns 56% | |||||
| of Class A stock, will tender its | |||||
| shares; another 2.3M Class A shares | |||||
| are subject to stock options, making | |||||
| the total value $3.7B (Monsanto will | |||||
| pay $2.5B for the shares it is buying); | |||||
| Monsanto initiated its tender offer | |||||
| 5/15/98; because the Department of | |||||
| Justice needs additional information, | |||||
| the tender has been extended 3 times; | |||||
| currently, the tender has been extend- | |||||
| ed to 11/30/98, and Monsanto agreed | |||||
| not to close the acquisition before | |||||
| 11/16/98 | |||||
| Dinamilho Carol | Mycogen Corp. | 4/98 | 4/98 | ND | Mycogen's acquisition of Dinamilho |
| Productos Agricolas | was financed through a line of credit | ||||
| Ltda. (Brazil) | provided by Dow AgroSciences LLC | ||||
| DNAP Holding | Bionova Inter- | 7/98 | 4/99E | $30 | Bionova will invest $30M in DNAP |
| Corp. (majority- | national Inc. (wholly | Holding in exchange for 5.2M shares | |||
| owned subsidiary | owned subsidiary of | at $5.75/share; also, once current | |||
| of Bionova Inter- | Empresas La | shareholders approve issuance of new | |||
| national Inc.) | Moderna SA de CV; | shares, they get the right to acquire 3 | |||
| NYSE:ELM; Mexico) | shares for every 4 now owned at $5.75 | ||||
| per share; Bionova's stake increases | |||||
| from 70% to 80.6% | |||||
| Hybridos Colorado | Mycogen Corp. | 9/98 | 9/98 | ND | Mycogen's acquisitions of Hybridos |
| Ltda. and FT Bio- | Colorado and FT Biogenetica were | ||||
| genetica de Milho | financed through a line of credit pro- | ||||
| Ltda. (Brazil) | vided by Dow AgroSciences LLC | ||||
| Mycogen Corp. | Dow AgroSciences | 1/98 | 10/98 | $411.6 | In 1/98, Dow AgroSciences raised its |
| LLC (wholly owned | stake in Mycogen from 57.5% to 63% | ||||
| subsidiary of the | in exchange for $75M cash and Dow | ||||
| Dow Chemical Co.; | AgroScience's 16.25% equity stake in | ||||
| NYSE:DOW) | Verneuil Holdings (raising Mycogen's | ||||
| stake in Verneuil from 18.75% to | |||||
| 35%); in 3/98, Pioneer Hi-Bred Inter- | |||||
| national Inc. sold its remaining stake | |||||
| in Mycogen (2M shares, stems from a | |||||
| 1995 collaboration) to Dow Agro- | |||||
| Sciences for $40.1M ($20.06/share), | |||||
| raising Dow AgroSciences' stake to | |||||
| 69%; in 7/98, Mycogen's board | |||||
| approved an amendment to terms of | |||||
| original agreement so that Dow could | |||||
| acquire the rest of Mycogen before | |||||
| 2/99; the definitive agreement was | |||||
| reached in 8/98, when Dow Agro- | |||||
| Sciences initiated a $28/share tender | |||||
| offer; 14.7M shares were tendered; | |||||
| the offer closed 10/2/98 and the trans- | |||||
| action is scheduled to close 10/30/98 | |||||
| Prisma Acquisition | Synbiotics Corp. | 3/98 | 3/98 | $3 | In connection with the acquisition, |
| Corp.* | Synbiotics issued a $1M, 1-year note | ||||
| and unregistered stock and stock op- | |||||
| tions valued at $2M; Synbiotics will | |||||
| license back the non-animal-health | |||||
| rights for Prisma's blood chemistry | |||||
| system to a new company owned by | |||||
| Prisma's former shareholders | |||||
| VetLife subsidiary | Ivy Laboratories | 4/98 | 4/98 | $13 | CytRx sold all the assets of its VetLife |
| of CytRx Corp. | Inc. | subsidiary for $7.5M (consisting of a | |||
| cash payment and a subordinated note); | |||||
| CytRx will also get $5.5M contingent | |||||
| on future product sales by Ivy | |||||
| II. AGRIBUSINESS | |||||
| Cargill Hybrid | Hoechst Schering | 9/98 | 11/98E | $650 | AgrEvo will acquire Cargill's North |
| Seeds North | AgrEvo GmbH | American seed assets for $650M | |||
| America (unit of | (joint venture | ||||
| Cargill Inc.) | between Hoechst AG | ||||
| and Schering AG; | |||||
| Germany) | |||||
| Cargill International | Monsanto Co. | 6/98 | 4Q:98E | $1,400 | Monsanto will buy Cargill's inter- |
| Seeds (unit of | (NYSE:MTC) | national seed operations for $1.4B | |||
| Cargill Inc.) | |||||
| Delta & Pine Land | Monsanto Co. | 5/98 | 4Q:98E | $1,900 | Monsanto will acquire the 95.3% of |
| Co. (NYSE:DLP) | (NYSE:MTC) | Delta & Pine that it doesn't already | |||
| own in a stock swap; Delta & Pine | |||||
| shareholders get 0.8625 Monsanto | |||||
| share for 1 Delta & Pine share; | |||||
| Department of Justice requested more | |||||
| information in 8/98, extending the | |||||
| waiting period to close | |||||
| Monsanto Co. | American Home | 6/98 | Terminated | $34,000 | This transaction was termed a merger |
| (NYSE:MTC) | Products Corp. | 10/98 | of equals, but American Home share- | ||
| (NYSE:AHP) | holders were to retain their shares | ||||
| while Monsanto shareholders were to | |||||
| get 1.15 shares in the new company | |||||
| that was to be formed for each Mon- | |||||
| santo share; Monsanto shareholders | |||||
| were to own 35% of new company; the | |||||
| merger was terminated by mutual consent | |||||
| Plant Breeding | Monsanto Co. | 7/98 | 7/98 | $522 | Unilever sold Plant Breeding to Mon- |
| International | (NYSE:MTC) | santo for $522M cash | |||
| Cambridge Ltd. | |||||
| (subsidiary of Unilever | |||||
| plc; U.K.) | |||||
| NOTES: | |||||
| # This chart covers mergers and acquisitions announced between 1/1/98 and 10/19/98. | |||||
| ND = Not disclosed, reported and/or available | |||||
| ** Unless otherwise noted, the trading symbols for public biotechnology companies can be found by referring to the BioWorld Stock Report For Public Biotechnology Companies on pp. 12-13. | |||||
To read more on related topics, click on one of the words below.